Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CMPS
CMPS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMPS News
Helus Pharma Advances New Drug for Anxiety Treatment
21h ago
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
21h ago
PRnewswire
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
Feb 26 2026
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
Feb 26 2026
Newsfilter
Compass Pathways Exercises Warrants Raising $200 Million
Feb 26 2026
seekingalpha
Compass Pathways Exercises 35 Million Warrants for $200 Million
Feb 26 2026
Newsfilter
Mental Health Treatment Market Set for Accelerated Growth
Feb 24 2026
PRnewswire
Mental Health Drug Market Set for Accelerated Growth
Feb 24 2026
Newsfilter
Compass Pathways to Attend TD Cowen Healthcare Conference
Feb 24 2026
Businesswire
Weekly Roundup: Cannabis and Psychedelic Sector Developments
Feb 23 2026
Yahoo Finance
"Compass Pathways Secures Trial Victory and Rapid Funding with Magic Mushrooms and Cash"
Feb 20 2026
Marketbeat
ARK Invest Increases Figma Stake and Reduces DraftKings Holdings
Feb 20 2026
Yahoo Finance
Investors Focus on Fed Minutes and Walmart Earnings
Feb 19 2026
stocktwits
Compass Pathways Prices $150M Public Offering
Feb 19 2026
seekingalpha
Compass Pathways Prices Public Offering at $8.00 per ADS
Feb 19 2026
Businesswire
Compass Pathways Prices Public Offering at $8.00 per ADS
Feb 19 2026
Newsfilter
Show More News
